Cited by 13Advanced MRI Techniques and ApplicationsHemoglobinopathies and Related DisordersCerebral Venous Sinus Thrombosis

Evaluation of SWI in Children with Sickle Cell Disease

Open access
Winchell, A. M., Taylor, B. A., Song, R., Loeffler, R. B., Grundlehner, P., Hankins, J. S., Wang, W. C., Ogg, R. J. +2 more·2014·American Journal of Neuroradiology

Abstract

BACKGROUND AND PURPOSE: SWI is a powerful tool for imaging of the cerebral venous system. The SWI venous contrast is affected by blood flow, which may be altered in sickle cell disease. In this study, we characterized SWI venous contrast in patients with sickle cell disease and healthy control participants and examined the relationships among SWI venous contrast, and hematologic variables in the group with sickle cell disease. MATERIALS AND METHODS: A retrospective review of MR imaging and hematologic variables from 21 patients with sickle cell disease and age- and sex-matched healthy control participants was performed. A Frangi vesselness filter was used to quantify the attenuation of visible veins from the SWI. The normalized visible venous volume was calculated for quantitative analysis of venous vessel conspicuity. RESULTS: The normalized visible venous volume was significantly lower in the group with sickle cell disease vs the control group (P < .001). Normalized visible venous volume was not associated with hemoglobin, percent hemoglobin F, percent hemoglobin S, absolute reticulocyte count, or white blood cell count. A hypointense arterial signal on SWI was observed in 18 of the 21 patients with sickle cell disease and none of the 21 healthy control participants. CONCLUSIONS: This study demonstrates the variable and significantly lower normalized visible venous volume in patients with sickle cell disease compared with healthy control participants. Decreased venous contrast in sickle cell disease may reflect abnormal cerebral blood flow, volume, velocity, or oxygenation. Quantitative analysis of SWI contrast may be useful for investigation of cerebrovascular pathology in patients with sickle cell disease, and as a tool to monitor therapies. However, future studies are needed to elucidate physiologic mechanisms of decreased venous conspicuity in sickle cell disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3174/ajnr.a3794

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • More recent MRI evidence shows potential involvement of deep medullary veins.

    “more recent MRI evidence shows potential involvement of deep medullary veins (175, 176).”

    From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [176]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Winchell, A. M., Taylor, B. A., Song, R., Loeffler, R. B., Grundlehner, P., Hankins, J. S., Wang, W. C., Ogg, R. J., Hillenbrand, C. M., & Helton, K. J.
Affiliations
St. Jude Children's Research Hospital (US)
Venue
American Journal of Neuroradiology
Published
2013-11-21
Volume
35
Issue
5
Pages
1016-1021
ISSN
  • 0195-6108 (ISSN-L)
  • 1936-959X
OpenAlex
W2121567973
Cited by
13
References
29
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2021: 1 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 1
FWCI
1.03
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • American Journal of Neuroradiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Lebanese Syrian Associated Charities (NIH HL070590)
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (U54HL070590, HL070590)
  • National Cancer Institute (5R25CA02394, R25CA023944)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD049888)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Neurology › Cerebral Venous Sinus Thrombosis
Keywords
susceptibility-weighted imaging, sickle cell disease, cerebral venous system, cerebral blood flow, cerebrovascular pathology
MeSH terms
Algorithms, Anemia, Sickle Cell, Cerebral Veins, Child, Female, Humans, Image Enhancement, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Retrospective Studies, Sensitivity and Specificity, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review